TRIFIRO', Gianluca
 Distribuzione geografica
Continente #
EU - Europa 9.730
NA - Nord America 8.063
AS - Asia 5.438
SA - Sud America 2.021
AF - Africa 171
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 25.442
Nazione #
US - Stati Uniti d'America 7.891
RU - Federazione Russa 5.201
SG - Singapore 2.182
BR - Brasile 1.756
CN - Cina 1.505
IE - Irlanda 1.284
SE - Svezia 1.053
HK - Hong Kong 658
IT - Italia 445
VN - Vietnam 424
DE - Germania 350
FR - Francia 287
PL - Polonia 285
UA - Ucraina 223
FI - Finlandia 206
GB - Regno Unito 150
IN - India 150
AR - Argentina 96
CA - Canada 73
TR - Turchia 68
BD - Bangladesh 67
MX - Messico 59
EC - Ecuador 56
NL - Olanda 50
ZA - Sudafrica 49
IQ - Iraq 48
ID - Indonesia 42
PK - Pakistan 42
UZ - Uzbekistan 40
BE - Belgio 37
MA - Marocco 37
JP - Giappone 36
VE - Venezuela 36
RO - Romania 30
AT - Austria 21
PY - Paraguay 21
ES - Italia 19
CO - Colombia 17
KE - Kenya 17
SA - Arabia Saudita 17
TN - Tunisia 17
AE - Emirati Arabi Uniti 15
EG - Egitto 14
LT - Lituania 14
AZ - Azerbaigian 13
CL - Cile 13
PH - Filippine 12
DZ - Algeria 11
JO - Giordania 11
PE - Perù 11
AL - Albania 10
KZ - Kazakistan 10
MY - Malesia 10
NP - Nepal 10
OM - Oman 10
PA - Panama 10
AU - Australia 9
BO - Bolivia 9
CH - Svizzera 8
ET - Etiopia 8
IR - Iran 8
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
IL - Israele 6
LB - Libano 6
NI - Nicaragua 6
BY - Bielorussia 5
CR - Costa Rica 5
JM - Giamaica 5
QA - Qatar 5
RS - Serbia 5
UY - Uruguay 5
BN - Brunei Darussalam 4
CI - Costa d'Avorio 4
EE - Estonia 4
GR - Grecia 4
KR - Corea 4
LK - Sri Lanka 4
LV - Lettonia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
BG - Bulgaria 3
CY - Cipro 3
EU - Europa 3
GA - Gabon 3
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
MD - Moldavia 3
PT - Portogallo 3
SI - Slovenia 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
AO - Angola 2
BW - Botswana 2
Totale 25.410
Città #
Moscow 1.572
Dublin 1.273
Ashburn 1.243
Singapore 1.146
Chandler 999
Dallas 892
Hong Kong 657
Beijing 521
Jacksonville 510
Nyköping 491
Warsaw 272
The Dalles 270
Princeton 242
San Jose 223
Los Angeles 205
Lauterbourg 198
Medford 187
Cambridge 180
Messina 180
Dearborn 161
Des Moines 153
Dong Ket 135
Ann Arbor 133
São Paulo 122
New York 112
Boardman 102
Ho Chi Minh City 101
Munich 89
Buffalo 85
Redondo Beach 85
Tianjin 82
Wilmington 70
Hanoi 60
Guangzhou 59
Shenyang 57
Rio de Janeiro 56
Jinan 51
Bremen 49
Orem 46
Council Bluffs 45
Belo Horizonte 44
Frankfurt am Main 41
San Mateo 39
Santa Clara 39
Tashkent 39
Brussels 37
Nanjing 35
Tokyo 35
Hyderabad 33
Rome 33
Chennai 32
Brasília 31
Houston 31
Seattle 30
Woodbridge 30
Focsani 29
Curitiba 28
Montreal 24
Pune 24
Chicago 23
Baghdad 22
Brooklyn 22
Haiphong 22
Helsinki 22
Johannesburg 22
Shanghai 22
Campinas 21
Milan 21
Denver 20
Guayaquil 20
Haikou 20
Nuremberg 20
Shenzhen 20
Falls Church 19
Hebei 19
Jakarta 19
Phoenix 19
Salvador 19
London 18
Porto Alegre 18
Turku 17
Amsterdam 16
Atlanta 16
Catania 16
Dhaka 16
Hangzhou 16
Ningbo 16
Taizhou 16
Ankara 15
Lanzhou 15
Nairobi 15
Ottawa 15
Stockholm 15
Fortaleza 14
Guarulhos 14
Juiz de Fora 14
Lancaster 14
Poplar 14
Quito 14
Santo André 14
Totale 14.478
Nome #
1. Real World Evidence vs. Real World Data: definizioni e razionale 258
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study 225
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study 221
Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach 203
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies 187
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study 185
Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. 184
Antidepressant use in the elderly: The role of pharmacodynamics and pharmacokinetics in drug safety 183
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study 182
Analgesic drug use in elderly persons: A population-based study in Southern Italy 181
Drug safety information through the internet: the experience of an Italian website. 176
Global epidemiology of acromegaly: A systematic review and meta-analysis 176
Absorbable phosphate in medication 171
12. Real World Evidence nelle valutazioni post‑marketing su farmaci generici e biosimilari 168
PATTERN PRESCRITTIVO DI FARMACI ANTIEPILETTICI NELL'ANZIANO: STUDIO DI POPOLAZIONE IN UN'AREA DEL SUD ITALIA NEGLI ANNI 2004-2007 166
How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016 166
Real world use of biological drugs in patients with psoriasis/psoriatic arthritis: a retrospective, population-based study from Southern Italy in the years 2010-2014 166
About reimbursement criteria revision: effects on lipid lowering drug use in general practice of Southern Italy 165
Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient's Quality of Life: A Single-Center, 10-Year Experience from Southern Italy 165
Adverse drug events in emergency department population: a prospective Italian study 163
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? 163
Antipsychotic use in dementia patients in a general practice setting: A Dutch population-based study 162
Gender differences in outpatient pediatric drug utilization: A cohort study from southern Italy 162
Challenges in Post-marketing Studies of Biological Drugs in the Era of Biosimilars: A Report of the International Society for Pharmacoepidemiology 2019 Mid-Year Meeting in Rome, Italy 161
A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. 159
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations 159
Acute cerebellar ataxia following meningococcal group C conjugate vaccination 156
Antipsychotic utilization patterns among patients with schizophrenic disorder: a cross-national analysis in four countries 156
The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy 156
Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: A population-based study 155
CEREBELLAR STROKE IN ELDERLY PATIENT WITH BASILAR ARTERY AGENESIA: A CASE REPORT. 155
Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in general practice 155
Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy 155
“Newer and older antiepileptic drug in southern Italy: a population based study during the years 2003-2005” 154
Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study 154
Burden of cardiovascular disease in elderly with Parkinson's disease who start a dopamine agonist agent 153
Overview of the Safety of Anti-VEGF Drugs: Analysis of the Italian Spontaneous Reporting System 151
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 151
Bisphosphonates and cardiovascular risk in elderly patients with previous cardiovascular disease: a population-based nested case-control study in Italy 151
Global epidemiology of Duchenne muscular dystrophy: An updated systematic review and meta-analysis 151
Age-related changes in pharmacodynamics: focus on drug acting on cetral nervous and cardiovascular systems 148
Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy 145
Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies 145
Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005. 144
Prescribing pattern of antiepileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-2007 143
Can information on functional and cognitive status improve short-term mortality risk prediction among community-dwelling older people? A cohort study using a UK primary care database 143
Kidney disease in diabetic patients: From pathophysiology to pharmacological aspects with a focus on therapeutic inertia 142
'Use of Antipsychotics in Children and Adolescents: A Picture From the ARITMO Population-Based European Cohort Study' 141
An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease 140
Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011 138
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 138
Prescribing pattern of drugs in the treatment of osteoarthritis before and after rofecoxib withdrawal in general practice of Southern Italy 137
Monoclonal antibodies for renal diseases: current concepts and ongoing treatments 137
Diagnostic Yield of 2 Strategies for Adult Celiac Disease Identification in Primary Care 135
Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses 135
Expert opinion of nephrologists about the effectiveness of low-protein diet in different stages of chronic kidney disease (CKD) 134
Adherence to gastroprotection during cyclooxygenase-2 inhibitor use and the risk of upper gastrointestinal events: A population-based study. 134
Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease 134
USE AND TOLERABILITY OF NEWER ANTIPSYCHOTICS AND ANTIDEPRESSANTS: A CHART REVIEW IN A PAEDIATRIC SETTING. 133
Parkinsonism and severe hypothyroidism in an elderly patient: a case of lithium toxicity due to pharmacological interactions. 131
Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision 130
Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy 129
Additional risk minimisation measures in the EU - are they eligible for assessment? 129
Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project 129
Profilo di tollerabilità degli antipsicotici atipici e degli inibitori selettivi della ricaptazione della serotonina in età evolutiva. 128
Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: A population-based cohort study 127
A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project. 126
A Reference Standard for Evaluation of Methods for Drug Safety Signal Detection using Electronic Healthcare Records (EHR) Databases 126
Ckd general and clinical epidemiology 2. 126
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in southern Italy 125
Gender differences in COPD management in a Sicilian general practice setting: a cohort study evaluating the impact of educational interventions 125
Adherence of Elderly Patients with Cardiovascular Disease to Statins and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease: Evidence from an Italian Real-World Investigation. 125
Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials. 124
Tolerability of antipsychotics in children and adolescents: a prospective study. 122
Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: the effect of rofecoxib withdrawal. 122
In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study 122
Global incidence and prevalence of differentiated thyroid cancer in childhood: systematic review and meta-analysis 121
Point-of-Care test screening versus Case finding for paediatric coeliac disease: A pragmatic study in primary care 120
From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources 120
Interaction risk with proton pump inhibitors in general practice: Significant disagreement between different drug-related information sources 120
Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile? 120
Adverse drug reaction-related hospitalizations in persons aged 55 years and over: a population-based study in The Netherlands 118
Adherence to Antidepressants and Mortality in Elderly Patients with Cardiovascular Disease. 118
Lipid-lowering drug use in general practice of Southern Italy: Effects of reimbursement criteria revision 117
Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources 117
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014 117
The economic burden of preventable adverse drug reactions: a systematic review of observational studies 117
Academic output from EU-funded health research projects 115
All-cause mortality and antipsychotic use among elderly persons with high baseline cardiovascular and cerebrovascular risk: a multi-center retrospective cohort study in Italy 114
Pharmacokinetics of new oral anticoagulants: implications for use in routine care 114
All-cause mortality associated with atypical and typical antipsychotics in demented outpatients 113
“Prescribing pattern of antipsychotic drugs in Italy: a population based study in the the years 2000-2005” 111
Medication is an additional source of phosphate intake in chronic kidney disease patients 110
Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during 1999-2002 years 109
Improvement in the management of chronic obstructive pulmonary disease following a clinical educational program: results from a prospective cohort study in the Sicilian general practice setting 109
The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study 109
Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? 108
Intravitreal Anti-VEGF Drugs and Signals of Dementia and Parkinson-Like Events: Analysis of the VigiBase Database of Spontaneous Reports 108
Use of azithromycin and risk of ventricular arrhythmia 108
Data Extraction And Management In Networks Of Observational Health Care Databases For Scientific Research: A Comparison Among EU-ADR, OMOP, Mini-Sentinel And MATRICE Strategies 106
Totale 14.341
Categoria #
all - tutte 91.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021332 0 0 0 0 0 0 0 0 0 142 29 161
2021/20221.463 7 97 16 41 39 14 72 71 36 409 157 504
2022/20233.612 291 266 161 289 296 347 43 184 1.582 13 109 31
2023/2024871 76 154 52 84 78 173 26 54 3 49 10 112
2024/20254.331 61 59 78 241 164 113 101 1.003 1.188 262 317 744
2025/202612.061 563 828 1.018 845 1.087 2.728 1.374 1.651 1.509 458 0 0
Totale 26.015